Digital Health Solutions for Community-Based Control of Diabetes During COVID-19 Pandemic: A Scoping Review of Implementation Outcomes.
COVID-19
Digital health
diabetes
implementation outcomes
review
Journal
Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166
Informations de publication
Date de publication:
13 Apr 2023
13 Apr 2023
Historique:
entrez:
14
4
2023
pubmed:
15
4
2023
medline:
15
4
2023
Statut:
aheadofprint
Résumé
The COVID-19 pandemic has added to the pre-existing challenges of diabetes management in many countries. It has accelerated the wider use of digital health solutions which have tremendous potential to improve health outcomes for people with diabetes. However, little is known about the attributes and the implementation of these solutions. To identify and describe digital health solutions for community-based diabetes management and to highlight their key implementation outcomes. We searched Ovid Medline, CINAHL, Embase, PsycINFO, and Web of Science for relevant articles. A purposive search was also used to identify grey literature. Articles that described digital health solutions that aimed to improve community-based diabetes management were included in this review. We applied a thematic synthesis of evidence to describe the characteristics of digital health solutions, and to summarize their key implementation outcomes. We included 15 articles that reported digital health solutions that primarily focused on community-based diabetes management. Nine of the 15 innovations involved were mobile applications and/or web-based platforms, and five were based on social media platforms. The majority of the digital health solutions were used for diabetes education and support. High engagement, utilization, and satisfaction rates with digital health solutions were observed. The use of digital health solutions was also associated with improvement in self-management, taking medication, and reduction in glycated hemoglobin (HbA1c) levels. COVID-19 triggered digital health solutions have tremendous potential to improve health outcomes for people with diabetes. Further studies are needed to evaluate the sustainability and scale-up of these solutions.
Sections du résumé
BACKGROUND
UNASSIGNED
The COVID-19 pandemic has added to the pre-existing challenges of diabetes management in many countries. It has accelerated the wider use of digital health solutions which have tremendous potential to improve health outcomes for people with diabetes. However, little is known about the attributes and the implementation of these solutions.
OBJECTIVE
UNASSIGNED
To identify and describe digital health solutions for community-based diabetes management and to highlight their key implementation outcomes.
METHODS
UNASSIGNED
We searched Ovid Medline, CINAHL, Embase, PsycINFO, and Web of Science for relevant articles. A purposive search was also used to identify grey literature. Articles that described digital health solutions that aimed to improve community-based diabetes management were included in this review. We applied a thematic synthesis of evidence to describe the characteristics of digital health solutions, and to summarize their key implementation outcomes.
RESULTS
UNASSIGNED
We included 15 articles that reported digital health solutions that primarily focused on community-based diabetes management. Nine of the 15 innovations involved were mobile applications and/or web-based platforms, and five were based on social media platforms. The majority of the digital health solutions were used for diabetes education and support. High engagement, utilization, and satisfaction rates with digital health solutions were observed. The use of digital health solutions was also associated with improvement in self-management, taking medication, and reduction in glycated hemoglobin (HbA1c) levels.
CONCLUSION
UNASSIGNED
COVID-19 triggered digital health solutions have tremendous potential to improve health outcomes for people with diabetes. Further studies are needed to evaluate the sustainability and scale-up of these solutions.
Identifiants
pubmed: 37056165
doi: 10.1177/19322968231167853
pmc: PMC10102819
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
19322968231167853Références
Diabet Med. 2021 Mar;38(3):e14469
pubmed: 33274489
BMJ Open. 2021 Jan 19;11(1):e043590
pubmed: 33468529
J Diabetes Sci Technol. 2023 Mar;17(2):353-363
pubmed: 34719972
Nat Med. 2020 Aug;26(8):1183-1192
pubmed: 32770165
Nat Rev Endocrinol. 2021 Jan;17(1):11-30
pubmed: 33188364
Lancet. 2018 Nov 10;392(10159):1683
pubmed: 30415747
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
PLoS One. 2018 Jun 1;13(6):e0198343
pubmed: 29856828
Indian J Endocrinol Metab. 2021 Mar-Apr;25(2):86-92
pubmed: 34660235
Lancet Digit Health. 2021 Jun;3(6):e383-e396
pubmed: 33967002
J Diabetes Investig. 2022 Aug;13(8):1448-1457
pubmed: 35394118
Front Pharmacol. 2020 Mar 20;11:108
pubmed: 32265688
JMIR Diabetes. 2022 Jun 24;7(2):e37882
pubmed: 35537057
Lancet. 2020 Sep 5;396(10252):649
pubmed: 32891195
Asia Pac J Public Health. 2022 May;34(4):377-383
pubmed: 35016535
JMIR Diabetes. 2022 May 30;7(2):e37534
pubmed: 35635752
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
J Gen Intern Med. 2023 Jan;38(1):131-137
pubmed: 35581452
Patient Prefer Adherence. 2022 Jan 15;16:113-122
pubmed: 35068927
J ASEAN Fed Endocr Soc. 2020;35(1):33-39
pubmed: 33442167
Implement Sci Commun. 2022 Jan 24;3(1):5
pubmed: 35074020
BMC Med Res Methodol. 2018 Nov 19;18(1):143
pubmed: 30453902
JMIR Diabetes. 2021 Jul 9;6(3):e25820
pubmed: 34111018
J Diabetes Sci Technol. 2021 Jan;15(1):121-126
pubmed: 32146839
Front Digit Health. 2021 Aug 03;3:647938
pubmed: 34713117
J Med Internet Res. 2022 Mar 23;24(3):e31449
pubmed: 35319478
Prim Care Diabetes. 2021 Jun;15(3):417-423
pubmed: 33422431
Can J Cardiol. 2022 Feb;38(2):279-291
pubmed: 34863912
Front Public Health. 2022 Mar 14;10:748157
pubmed: 35359772
JAMA Netw Open. 2021 Nov 1;4(11):e2133129
pubmed: 34735015
Curr Diab Rep. 2020 Oct 10;20(11):62
pubmed: 33037442